HealthQuill RSV vaccine
Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,” after a single jab, according to a company statement. 
Drugs Health Pharma

‘Strong neutralizing responses’ shown in RSV vaccine trials: Pfizer says

Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,”.

Read More
Chongqing Zhifei Biological Products, the largest Chinese vaccine company by revenue, will buy shingles vaccines from GSK Plc., worth $3 billion to distribute in the Asian country.
Drugs Health Pharma

China’s Zhifei in $3 billion distribution deal with GSK for shingles vaccine

HQ Team October 10, 2023: Chongqing Zhifei Biological Products, the largest Chinese vaccine company by revenue, will buy shingles vaccines from GSK Plc.,.

Read More
X